Over the 20 years I've been treating breast cancer, I think this is the one area where we've really lagged behind in terms of making progress, said Andrew Seidman, MD, attending Physician, Memorial Sloan-Kettering Cancer Center, New York, NY.
“Over the 20 years I’ve been treating breast cancer, I think this is the one area where we've really lagged behind in terms of making progress,” said Andrew Seidman, MD, attending Physician, Memorial Sloan-Kettering Cancer Center, New York, NY.
Dr Seidman says that at the Annual Meeting of the American Society of Clinical Oncologists in Chicago, Aki Morikawa, MD, PhD, Memorial Sloan-Kettering Cancer Center, will present data on two commonly used breast cancer drugs, capecitabine and Lapatinib, to penetrate into breast cancer brain metastases. The observations found in the study should motivate further studies to examine the use of these agents.
This video was taken on May 31, 2013, at the ASCO Annual Meeting 2013 in Chicago, IL.
GLP-1 Receptor Agonists Reduce Adverse Cardiovascular Outcomes, Improve Survival
August 2nd 2025Studies found that glucagon-like peptide-1 (GLP-1) receptor agonists were valuable tools in improving outcomes and survival in those with coronary plaque and after ST-elevation myocardial infarction.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Legal Navigation Services Key to Addressing Disparities in Cancer Care
July 31st 2025A significant number of patients with cancer, caregivers, and health care professionals face significant disparities in legal issues, with the most common needs revolving around health insurance, finances, employment, and disability insurance.
Read More